Thomas Glocer

Insider profile

Currently holds positions in Merck & Co Inc, Publicis Groupe SA and Morgan Stanley

Performance

Overall performance
1.9

Performance over holding periods
1.9
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 34% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Merck & Co Inc Nov. 27, 2007 -
Independent Member of the Supervisory Board Publicis Groupe SA May 25, 2016 -
Lead Independent Director Morgan Stanley Sept. 1, 2017 -
Independent Director Morgan Stanley Jan. 1, 2013 - Sept. 1, 2017

Thomas Glocer's trades of Informa PLC's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
165.30
Quantity 17,799
Value £396,017
Transaction date
Sale
Price
305.38
Quantity 66,461 -30.4%
Value US$2,071,286
Transaction date
Proposed sale
Price
227.31
Quantity 6,434
Value US$2,413,932
Transaction date
Sale
Price
75.96
Quantity 10,000 -66.2%
Value US$759,590
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-12 2026-10-06 B Purchase
17,799
165.30
£396,017
17,799 165.30 £396,017
2023-05-05 2023-05-03 S Sale
66,461 -30.4%
305.38
US$2,071,286
66,461 -30.4% 305.38 US$2,071,286
2023-05-03 2023-05-03 PrS Proposed sale
6,434
227.31
US$2,413,932
6,434 227.31 US$2,413,932
2019-02-04 2019-02-04 S Sale
10,000 -66.2%
75.96
US$759,590
10,000 -66.2% 75.96 US$759,590